2018 Press Releases

Keyword Search
 
October 30, 2018
Covalon Announces Successful Completion of Operational Integration of AquaGuard Acquisition amid Continued Business Progress

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Oct. 30, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announces that it has successfully completed the integration of AquaGuard with its operations. AquaGuard, based in Seattle, Washington, was acquired by Covalon on October 1, 2018. AquaGuard's specialized products provide patients with crucial moisture protec... Read More »

Printer Friendly Version 
October 24, 2018
Covalon to Showcase AquaGuard® and IV Clear™ Products to Over 9,000 Nurses at Prestigious ANCC Magnet Conference

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Oct. 24, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV) (OTCQX:CVALF), an advanced medical technologies company, today announces that it will be showcasing newly-acquired moisture barrier line AquaGuard® as part of its portfolio of infection prevention products at the 2018 American Nurses Credentialing Center National Magnet Conference (the “Magnet Conference”). The Magnet Conference will t... Read More »

Printer Friendly Version 
October 01, 2018
Covalon Announces Closing of AquaGuard Acquisition Combining Covalon’s Rich Technology Portfolio with AquaGuard’s Excellent Products and Specialized Salesforce Capable of Selling Covalon’s Products Throughout the United States

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Oct. 1, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it has closed the acquisition (the “Closing”) of AquaGuard, the Seattle, Washington-based division of medical technologies company Cenorin, LLC. AquaGuard's specialized products provide patients with crucial moisture protection for wound, surgical, and vascul... Read More »

Printer Friendly Version 
September 28, 2018
Covalon Announces Issuance of Stock Options

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Sep. 28, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV.V)(OTCQX:CVALF), an advanced medical technologies company, today announced the issuance of an aggregate of 155,000 stock options to directors, officers and staff of the Company. The stock options will vest over three years and will be exercisable for a period of five years at an exercise price of $8.50 per stock option. A... Read More »

Printer Friendly Version 
September 20, 2018
Covalon to Host Conference Call to Discuss Definitive Agreement to Acquire AquaGuard

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Sep. 20, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has scheduled a conference call for Friday September 21st 2018 at 9:00am EST. The conference call is being held to discuss the announcement of Covalon’s definitive agreement to acquire AquaGuard, the Seattle, Washington-based division of medical technologies company Ceno... Read More »

Printer Friendly Version 
September 20, 2018
Covalon Announces Definitive Agreement to Acquire AquaGuard and its Specialized Salesforce Capable of Selling Covalon’s Products Throughout the United States

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Sep. 20, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV.V; OTCQX: CVALF), an advanced medical technologies company, today announces that it has entered into a definitive agreement to acquire AquaGuard, the Seattle, Washington-based division of medical technologies company Cenorin, LLC. AquaGuard’s specialized products provide patients with crucial moisture protection for wound, surgical, an... Read More »

Printer Friendly Version 
September 14, 2018
Covalon to Showcase IV Clear at AVA Scientific Meeting 2018

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Sep. 14, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV.V; OTCQX: CVALF), an advanced medical technologies company, today announces that it will be showcasing IV Clear at the 2018 Scientific Meeting for the Association for Vascular Access (“AVA” or the “Meeting”). Covalon’s IV Clear™ is indicated to cover and protect vascular access devices used in a wide variety of both acute and a... Read More »

Printer Friendly Version 
August 28, 2018
Covalon Announces Another Milestone Quarterly Profit on Excellent Third Quarter Financial Results

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Aug. 28, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce today another milestone quarterly profit of $2.2 million on excellent third quarter financial results. Third Quarter Summary Financial Results Revenue for the three months ended June 30, 2018 was $7,933,676, up 34%. ... Read More »

Printer Friendly Version 
August 20, 2018
Covalon Announces Receipt of First Payment Under New License Agreement

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Aug. 20, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it has received $3.5 million USD under a new license agreement (“Agreement”) with a large global medical company (“Medical Partner”). The Agreement provides the Medical Partner with certain rights to use Covalon’s patented antimicrobial medical coating techn... Read More »

Printer Friendly Version 
August 09, 2018
Covalon Announces Major Banking Milestone

• New $17 million acquisition and operating banking facility with major international bank HSBC and Export Development Canada. • Credit facility will allow Covalon to fund its acquisition plans which are proceeding well. MISSISSAUGA, Ontario--(BUSINESS WIRE)--Aug. 9, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that the Company has ent... Read More »

Printer Friendly Version 
August 07, 2018
Covalon Unaware of Any Material Change

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Aug. 7, 2018-- At the request of the Investment Industry Regulatory Organization of Canada (“IIROC”), Covalon Technologies Ltd. (“Covalon” or the “Company”) wishes to confirm that the Company’s management is unaware of any material change in the Company’s operations that would account for the recent increase in market activity. Management of the Company does not believe, based on its communications with the Company’... Read More »

Printer Friendly Version 
July 26, 2018
Covalon Announces Retirement of Member of Board of Directors

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Jul. 26, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announces that Martin Bernholtz has retired as a member of the Board of Directors of the Company, effective at the end of this month, on July 31st 2018. “We would like to thank Martin Bernholtz for his many years of service to the Company,” said Brian Pedlar... Read More »

Printer Friendly Version 
June 12, 2018
Covalon Technologies Ltd. to Exhibit at the Largest Annual Infection Prevention and Control Conference in the World

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Jun. 12, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will exhibit at the APIC 2018 Conference in Minneapolis, Minnesota, June 13th to 15th. Covalon will be showcasing its unique line of antimicrobial self-adherent silicone products, including MediClear™ PreOp, the market’s first breathable an... Read More »

Printer Friendly Version 
May 28, 2018
Covalon Announces Major Corporate Initiatives and Second Quarter Results

Special Committee of the Board formed to evaluate acquisitions, strategic alliances, and partnerships as a result of recent announcement of $100 million in contract awards Significant progress is being made on the evaluation of potential accretive acquisitions Covalon to consider the potential for buy-back of shares at the appropriate time Covalon intends to utilize operating cash flows... Read More »

Printer Friendly Version 
May 28, 2018
Covalon to Host Conference Call to Discuss Release of Q2 Results and Initiatives

MISSISSAUGA, Ontario--(BUSINESS WIRE)--May 28, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV; OTCQX:CVALF) an advanced medical technologies company, has scheduled a conference call for Tuesday May 29th 2018 at 9:00 am ET. The conference call is being held to discuss the announcement of the financial results of the second quarter ended March 31st 2018 and initiatives being pursued by the Company. A news rel... Read More »

Printer Friendly Version 
May 22, 2018
Covalon Provides Further Information Regarding Estimated $100 Million Competitive Contract Awards

Covalon wins every single Vascular Access dressing category for the next three years in the Gulf Cooperation Council States in the Middle East MISSISSAUGA, Ontario--(BUSINESS WIRE)--May 22, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV; OTCQX:CVALF), an advanced medical technologies company, is pleased to provide further information on the previously-announced series of competitive contracts in the Middle ... Read More »

Printer Friendly Version 
May 07, 2018
Covalon Announces Major Sales Breakthrough – Wins Contracts with an Estimated Value of $100 Million Over a Three-Year Period

Conference call scheduled for Tuesday May 8th at 9am EDT to discuss the impact of this major transformative event MISSISSAUGA, Ontario--(BUSINESS WIRE)--May 7, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has been informed that it has won a series of competitive contracts in the Middle East with an estimated sales value of $100 million over a three-year ... Read More »

Printer Friendly Version 
April 30, 2018
Covalon to Showcase MediClear™ PreOp at AATS 2018 Annual Meeting

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Apr. 30, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be showcasing its perioperative suite of innovative products, including MediClear™ PreOp, at the American Association for Thoracic Surgery (“AATS”) Annual Meeting. MediClear PreOp is the market’s first breathable and transparent antimi... Read More »

Printer Friendly Version 
April 26, 2018
New Clinical Data for Covalon’s ColActive® Line of Patented Advanced Wound Care Products to be Presented at SAWC Spring

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Apr. 26, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, today announced that two clinical case studies demonstrating the clinical effectiveness of ColActive® Plus and ColActive® Transfer biological matrix products will be presented at the 2018 Symposium on Advanced Wound Care Spring (“SAWC Spring”) in Charlotte, North Carolina. In addition to the ... Read More »

Printer Friendly Version 
April 18, 2018
Covalon Unaware of Any Material Change

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Apr. 18, 2018-- At the request of the Investment Industry Regulatory Organization of Canada (“IIROC”), Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), wishes to confirm that the Company’s management is unaware of any material change in the Company’s operations that would account for the recent increase in market activity. About Covalon Covalon Technologies Ltd. researches, ... Read More »

Printer Friendly Version 
March 26, 2018
Covalon to Feature MediClear™ PreOp at AORN Surgical Conference and Expo 2018

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Mar. 26, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be featuring its perioperative suite of innovative products including MediClear™ PreOp at the Association of periOperative Registered Nurse’s (AORN) Surgical Conference and Expo, the largest international gathering of perioperative registered nurses ... Read More »

Printer Friendly Version 
March 09, 2018
Covalon Announces Voting Results from 2018 Annual Meeting of Shareholders

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Mar. 9, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, today announced the results of the matters voted upon at the Company’s 2018 Annual Meeting of Shareholders held March 8th 2018. Shareholders voted in favour of all items of business and each was approved by the requisite number of votes. The matters included the election of the ... Read More »

Printer Friendly Version 
March 05, 2018
Covalon’s MediClear™ PreOp Receives Frost & Sullivan’s 2018 North American Surgical Site Infection Prevention New Product Innovation Award

MediClear PreOp is a novel pre-operative film drape designed to reduce the level of bacteria on a patient’s skin before a surgical procedure. Frost & Sullivan is a global research organization that monitors more than 300 industries and 25,000 companies. MISSISSAUGA, Ontario--(BUSINESS WIRE)--Mar. 5, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologi... Read More »

Printer Friendly Version 
March 01, 2018
Covalon Annual Shareholders’ Meeting to be Held Thursday March 8th 2018 at 3:30pm EST

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Mar. 1, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), announced a reminder that the Company’s Annual and Special Shareholders’ Meeting will be held at the offices of Stikeman Elliott LLP, 53rd floor, Commerce Court West, 199 Bay Street, Toronto, Ontario, on Thursday March 8th 2018 at 3:30pm EST. About Covalon Covalon Technologies Ltd. researches, deve... Read More »

Printer Friendly Version 
February 20, 2018
Covalon Announces its Participation in Medical Japan 2018

Covalon to showcase its proprietary advanced wound and infection control products as part of the Ontario Government’s Life Sciences Trade Mission to Japan. Medical Japan is the country’s largest trade show focusing on products, services and technologies for healthcare. MISSISSAUGA, Ontario--(BUSINESS WIRE)--Feb. 20, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), ... Read More »

Printer Friendly Version 
February 12, 2018
Covalon Announces Strong First Quarter Financial Results

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Feb. 12, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced today its first quarter financial results. First Quarter Summary Financial Results Revenue for the three months ended December 31, 2017 was $6,404,705. Gross margin for the quarter ended December 31, 2017 was 71%. ... Read More »

Printer Friendly Version 
February 09, 2018
Covalon Announces Conference Call to Discuss Q1 Financial Results

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Feb. 9, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, has scheduled a conference call to be held Tuesday February 13th 2018 at 9:00 a.m. EST, to discuss the financial results of the first quarter ended December 31st 2017. The Company intends to release its Q1 financial results on Monday February 12th 2018. To participate in the liv... Read More »

Printer Friendly Version 
February 05, 2018
Covalon to Showcase Centaur™ Low Particulate, Lubricious Coating at MD&M West

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Feb. 5, 2018-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, today announced that it will be featuring its commercially available platform technologies, including the recently launched Centaur™ coating as first-time exhibitors at North America’s largest annual MedTech event. MD&M West will take place at the Anaheim Convention Center, from February 6... Read More »

Printer Friendly Version 
January 24, 2018
Covalon Announces Issuance of Stock Options

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Jan. 24, 2018-- Further to its press release dated October 27, 2017, Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the second tranche issuance of a further 60,000 stock options to certain financial advisors of the Company. The stock options will vest over three years and will be exercisable for a period of five years at an ... Read More »

Printer Friendly Version